Continuous Renal Replacement Therapy Consumables Market Size to Hit USD 2,069.01 Million by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Continuous Renal Replacement Therapy Consumables Market

5.1. COVID-19 Landscape: Continuous Renal Replacement Therapy Consumables Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Continuous Renal Replacement Therapy Consumables Market, By Consumable Type

8.1. Continuous Renal Replacement Therapy Consumables Market, by Consumable Type

8.1.1. Dialyzers/Filters

8.1.1.1. Market Revenue and Forecast

8.1.2. Bloodlines, Tubing & Sets

8.1.2.1. Market Revenue and Forecast

8.1.3. Replacement Fluids & Solutions

8.1.3.1. Market Revenue and Forecast

8.1.4. Anticoagulants & Additives

8.1.4.1. Market Revenue and Forecast

8.1.5. Connectors, Fittings & Accessories

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Continuous Renal Replacement Therapy Consumables Market, By Material/Technology

9.1. Continuous Renal Replacement Therapy Consumables Market, by Material/Technology

9.1.1. High-flux/High-efficiency Filters

9.1.1.1. Market Revenue and Forecast

9.1.2. Low-flux Filters

9.1.2.1. Market Revenue and Forecast

9.1.3. Biocompatible/Synthetic Membranes

9.1.3.1. Market Revenue and Forecast

9.1.4. Other Material Types

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Continuous Renal Replacement Therapy Consumables Market, By Treatment Type

10.1. Continuous Renal Replacement Therapy Consumables Market, by Treatment Type

10.1.1. CVVH (Continuous Venovenous Hemofiltration)

10.1.1.1. Market Revenue and Forecast

10.1.2. CVVHD (Continuous Venovenous Hemodialysis)

10.1.2.1. Market Revenue and Forecast

10.1.3. CVVHDF (Continuous Venovenous Hemodiafiltration)

10.1.3.1. Market Revenue and Forecast

10.1.4. Other CRRT Modalities

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Continuous Renal Replacement Therapy Consumables Market, By End-User

11.1. Continuous Renal Replacement Therapy Consumables Market, by End-User

11.1.1. Hospitals & ICUs

11.1.1.1. Market Revenue and Forecast

11.1.2. Dialysis & Specialty Care Centers

11.1.2.1. Market Revenue and Forecast

11.1.3. Ambulatory & Outpatient Clinics

11.1.3.1. Market Revenue and Forecast

11.1.4. Research & Academic Institutes

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Continuous Renal Replacement Therapy Consumables Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Consumable Type

12.1.2. Market Revenue and Forecast, by Material/Technology

12.1.3. Market Revenue and Forecast, by Treatment Type

12.1.4. Market Revenue and Forecast, by End-User

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Consumable Type

12.1.5.2. Market Revenue and Forecast, by Material/Technology

12.1.5.3. Market Revenue and Forecast, by Treatment Type

12.1.5.4. Market Revenue and Forecast, by End-User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Consumable Type

12.1.6.2. Market Revenue and Forecast, by Material/Technology

12.1.6.3. Market Revenue and Forecast, by Treatment Type

12.1.6.4. Market Revenue and Forecast, by End-User

12.2. Europe

12.2.1. Market Revenue and Forecast, by Consumable Type

12.2.2. Market Revenue and Forecast, by Material/Technology

12.2.3. Market Revenue and Forecast, by Treatment Type

12.2.4. Market Revenue and Forecast, by End-User

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Consumable Type

12.2.5.2. Market Revenue and Forecast, by Material/Technology

12.2.5.3. Market Revenue and Forecast, by Treatment Type

12.2.5.4. Market Revenue and Forecast, by End-User

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Consumable Type

12.2.6.2. Market Revenue and Forecast, by Material/Technology

12.2.6.3. Market Revenue and Forecast, by Treatment Type

12.2.6.4. Market Revenue and Forecast, by End-User

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Consumable Type

12.2.7.2. Market Revenue and Forecast, by Material/Technology

12.2.7.3. Market Revenue and Forecast, by Treatment Type

12.2.7.4. Market Revenue and Forecast, by End-User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Consumable Type

12.2.8.2. Market Revenue and Forecast, by Material/Technology

12.2.8.3. Market Revenue and Forecast, by Treatment Type

12.2.8.4. Market Revenue and Forecast, by End-User

12.3. APAC

12.3.1. Market Revenue and Forecast, by Consumable Type

12.3.2. Market Revenue and Forecast, by Material/Technology

12.3.3. Market Revenue and Forecast, by Treatment Type

12.3.4. Market Revenue and Forecast, by End-User

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Consumable Type

12.3.5.2. Market Revenue and Forecast, by Material/Technology

12.3.5.3. Market Revenue and Forecast, by Treatment Type

12.3.5.4. Market Revenue and Forecast, by End-User

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Consumable Type

12.3.6.2. Market Revenue and Forecast, by Material/Technology

12.3.6.3. Market Revenue and Forecast, by Treatment Type

12.3.6.4. Market Revenue and Forecast, by End-User

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Consumable Type

12.3.7.2. Market Revenue and Forecast, by Material/Technology

12.3.7.3. Market Revenue and Forecast, by Treatment Type

12.3.7.4. Market Revenue and Forecast, by End-User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Consumable Type

12.3.8.2. Market Revenue and Forecast, by Material/Technology

12.3.8.3. Market Revenue and Forecast, by Treatment Type

12.3.8.4. Market Revenue and Forecast, by End-User

12.4. MEA

12.4.1. Market Revenue and Forecast, by Consumable Type

12.4.2. Market Revenue and Forecast, by Material/Technology

12.4.3. Market Revenue and Forecast, by Treatment Type

12.4.4. Market Revenue and Forecast, by End-User

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Consumable Type

12.4.5.2. Market Revenue and Forecast, by Material/Technology

12.4.5.3. Market Revenue and Forecast, by Treatment Type

12.4.5.4. Market Revenue and Forecast, by End-User

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Consumable Type

12.4.6.2. Market Revenue and Forecast, by Material/Technology

12.4.6.3. Market Revenue and Forecast, by Treatment Type

12.4.6.4. Market Revenue and Forecast, by End-User

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Consumable Type

12.4.7.2. Market Revenue and Forecast, by Material/Technology

12.4.7.3. Market Revenue and Forecast, by Treatment Type

12.4.7.4. Market Revenue and Forecast, by End-User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Consumable Type

12.4.8.2. Market Revenue and Forecast, by Material/Technology

12.4.8.3. Market Revenue and Forecast, by Treatment Type

12.4.8.4. Market Revenue and Forecast, by End-User

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Consumable Type

12.5.2. Market Revenue and Forecast, by Material/Technology

12.5.3. Market Revenue and Forecast, by Treatment Type

12.5.4. Market Revenue and Forecast, by End-User

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Consumable Type

12.5.5.2. Market Revenue and Forecast, by Material/Technology

12.5.5.3. Market Revenue and Forecast, by Treatment Type

12.5.5.4. Market Revenue and Forecast, by End-User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Consumable Type

12.5.6.2. Market Revenue and Forecast, by Material/Technology

12.5.6.3. Market Revenue and Forecast, by Treatment Type

12.5.6.4. Market Revenue and Forecast, by End-User

Chapter 13. Company Profiles

13.1. Baxter International Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Fresenius Medical Care AG & Co. KGaA

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. B. Braun SE

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Medtronic plc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Nipro Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Asahi Kasei Medical Co., Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Nikkiso Co., Ltd.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Toray Medical Co., Ltd.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Infomed SA

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Medica S.p.A.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The continuous renal replacement therapy consumables market size is expected to increase from USD 920.17 million in 2025 to USD 2,069.01 million by 2035.

Answer : The continuous renal replacement therapy consumables market is expected to grow at a compound annual growth rate (CAGR) of around 8.44% from 2026 to 2035.

Answer : The driving factors of the continuous renal replacement therapy consumables market are the rising incidence of acute kidney injuries in critically ill patients and the increasing use of CRRT in intensive care units.

Answer : North America region will lead the global continuous renal replacement therapy consumables market during the forecast period 2026 to 2035.